Read the full judgment text of HCMP 2067/2020 on BabelCite. This High Court CFI judgment was delivered on 13 September 2024.
1. This is the trial of the petition presented on 16 November 2020 (“ Petition ”) by the Securities and Futures Commission (“ SFC ”) under s.214 of the Securities and Futures Ordinance (Cap. 571) (“ SFO ”) against the 1 st Respondent, Mr Zhou Ling (周凌) (“ R1” ), and the 2 nd Respondent, Mr Dai Haidong (戴海東) (“ R2” ), who were former executive directors of New Ray Medicine International Holding Limited (新銳醫藥國際控股有限公司) (“ Company” ).
Cited by 2 cases · Cites 7 cases